The Ultimate Guide 2018 to SARMS

2 Dec

The Ultimate Guide 2018 to SARMS


The topic of SARMs (or selective androgen receptor modulators) has been controversial since the beginning of the 1990s when it was created in the mainstream of science. This does not mean that SARMs did not exist long before this period.

Let’s look at some of the benefits and guide in more detail

Increased muscle strength

In the Asian press of Andrology, patients have muscle strength 20 times that of the placebo group. Patients should increase their strength and muscle tissue growth for up to five months but significantly decrease after three months (Dalton et al., 2014).

Muscle mass increase

Diluting evidence showed a marked increase in muscle tissue hypertrophy (increased muscle tissue). Inductive evidence suggests that operators receive 3 to 15 pounds of muscle within 12 weeks (Dubois et al., 2015). The amount of muscle growth depends on the feeding, physical and SARMs properties. Mild SARMs, such as MK2866, has significantly less hypertrophy, stronger than MRSA, such as RAD140 or LGD4033.

Tissue selectivity

Based on the Oxford Academic Journal of Endocrinology, nonsteroidal SARMs are intended to confirm the region of DNA responsible for the synthesis of skeletal muscle proteins. Unlike other anabolic agents, nonsteroidal SARMs remains unchanged in the body (Dubois et al., 2015).


Inhibits cancer cell division

Sharing research (PLoS), a review peer-reviewed Open Access Journal, an independent muscle research, and development study has been investigated steroid-I SARMs, which affects breast cancer. It is known that androgen receptors in breast cancer, and therefore plays a key role of steroidal SARMs are capable of estrogen, the negative consequences of the very narrow probability. The results not only confirmed that tumor cells reduce weight by 90% but even suppressed the development of breast cancer (Dalton et al., 2014). Read more:

Regulation of libido

Recent research has shown that male and female reproductive organs healthy growth of non-steroidal SARMs. Hypogonadism in men is a common practice in the treatment of testosterone. Testosterone therapy has many side effects that cause serious consequences for the user, such as thickening of the blood (usually causes a heart attack and stroke) or enlargement of prostate cancer and gynecomastia (breasts) in men) due to overproduction of estrogen.

Asian Journal of Andrology published in an edition of 2014 years, said that “favorable magic pharmacology and desirable pharmacokinetic properties offer a huge potential late hypogonadism. Oral administration of a day with an established security options surrounding that have proven effective doses can be used for the publication of a standard gold testosterone replacement therapy at the end of hypogonadism “( Dalton et al., 2014). Journal of Pharmacology and Experimental Therapeutics, the researchers, reported positive effects of non-steroidal MRSA low-sex motivation in women, who showed a significant increase in sexual services (Jones et al., 2010).

Safety and tolerance

Oxford Journal of Gerontology Series: Biological Sciences and Medical Sciences, a popular non-steroidal LGD 4033 MRSA (Ligandrol) have recently studied because it is young men about the effectiveness and safety of health. The results were useful for hormones and lipids that were normalized without cycling. There was no danger in the study. Although the levels of testosterone and HDL cholesterol were significantly reduced, they were not significant enough to cause side effects. Because LGD 4033 is considered to be one of the most potent and potent NSAIDs, SARMs may be less effective in inducing side effects (Bhasin, 2010).


Most importantly, non-steroidal SARMs side effects, such as conversion to estrogen causing gynecomastia (swollen nipples, sensitive men), decreased libido, and liver and kidney damage (due to methylation). For more information visit: